Key Metrics of DaVita
Revenue$12.1B▲ 4.6% YoYFY 2023
Operating income$1.6B▲ 19.7% YoY
Net profit$957M▲ 22.4% YoY
Shareholders' equity$1.1B
Market cap$11.9BDVA · $186.10
About DaVita
Company details
- Website
- davita.com
- Listed
- NYSE: DVA
Company summary
Legal nameDaVita Inc.
TickerDVA
ExchangeNYSE
CountryUnited States
SEC CIK0000927066
Listed since—
IndustryMisc Health and Biotechnology Services
SectorOther Industries · Discovered Companies
Websitehttps://www.davita.com
US market & SEC filings
DVA · NYSE · SEC CIK 0000927066
Last price · 24 Oct 2026
$186.10
+5.25%
Market cap$11.9B
P/E25.1On FY 2023 diluted EPS
Volume931,352
SectorHealth CareMisc Health and Biotechnology Services
Country · IPOUnited States
DVA share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeDenver
GSTIN—
Email—
Websitehttps://www.davita.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
health care industry
Filings
No filings on record yet.